|
Originally published In Press as doi:10.1074/jbc.M111497200 on January 25, 2002
J. Biol. Chem., Vol. 277, Issue 17, 14821-14828, April 26, 2002
Abnormal Acidification of Melanoma Cells Induces Tyrosinase
Retention in the Early Secretory Pathway*
Ruth
Halaban §,
Robin S.
Patton¶,
Elaine
Cheng ,
Sherri
Svedine¶,
E. Sergio
Trombetta ,
Miriam L.
Wahl**,
Stephen
Ariyan , and
Daniel N.
Hebert¶§§
From the Departments of Dermatology, Cell
Biology, and  Plastic Surgery, Yale
University School of Medicine, New Haven, Connecticut 06520, the
¶ Department of Biochemistry and Molecular Biology, Program in
Molecular and Cellular Biology, University of Massachusetts,
Amherst, Massachusetts 01003, and the ** Department of
Biochemistry and Molecular Pharmacology, Thomas Jefferson University,
Philadelphia, Pennsylvania 19107
In tyrosinase-positive amelanotic melanoma cells,
inactive tyrosinase accumulates in the endoplasmic reticulum. Based on
studies described here, we propose that aberrant vacuolar proton ATPase (V-ATPase)-mediated proton transport in melanoma cells disrupts tyrosinase trafficking through the secretory pathway. Amelanotic but
not melanotic melanoma cells or normal melanocytes display elevated
proton export as observed by the acidification of the extracellular
medium and their ability to maintain neutral intracellular pH.
Tyrosinase activity and transit through the Golgi were restored by
either maintaining the melanoma cells in alkaline medium (pH 7.4-7.7)
or by restricting glucose uptake. The translocation of tyrosinase out
of the endoplasmic reticulum and the induction of cell pigmentation in
the presence of the ionophore monensin or the specific V-ATPase
inhibitors concanamycin A and bafilomycin A1 supported a role for
V-ATPases in this process. Because it was previously shown that
V-ATPase activity is increased in solid tumors in response to an
acidified environment, the appearance of hypopigmented cells in
tyrosinase-positive melanoma tumors may indicate the onset of enhanced
glycolysis and extracellular acidification, conditions known to favor
metastatic spread and resistance to weak base chemotherapeutic drugs.
*
This work was supported by U. S. Public Health Service
Grants AR39848 and CA44542 (to R. H.), AR41942 (to R. E. Tigelaar, Yale Skin Diseases Research Center), and CA79864 (to D. N. H.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence may be addressed: Dept. of Dermatology, Yale
University School of Medicine, P. O. Box 208059, HRT 610, 15 York St.,
New Haven, CT 06520-8059. Tel.: 203-785-4352; Fax: 203-785-7637;
E-mail: ruth.halaban@yale.edu.
§§
To whom correspondence may be addressed: Dept. of
Biochemistry & Molecular Biology, University of Massachusetts, Lederle
Graduate Research Tower, 818, Box 34505, Amherst, MA 01003. Tel.:
413-545-0079; Fax: 413-545-3291; dhebert@biochem.umass.edu.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Michaeli, G. Denkberg, K. Sinik, L. Lantzy, C. Chih-Sheng, C. Beauverd, T. Ziv, P. Romero, and Y. Reiter
Expression Hierarchy of T Cell Epitopes from Melanoma Differentiation Antigens: Unexpected High Level Presentation of Tyrosinase-HLA-A2 Complexes Revealed by Peptide-Specific, MHC-Restricted, TCR-Like Antibodies
J. Immunol.,
May 15, 2009;
182(10):
6328 - 6341.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Ginger, S. E. Askew, R. M. Ogborne, S. Wilson, D. Ferdinando, T. Dadd, A. M. Smith, S. Kazi, R. T. Szerencsei, R. J. Winkfein, et al.
SLC24A5 Encodes a trans-Golgi Network Protein with Potassium-dependent Sodium-Calcium Exchange Activity That Regulates Human Epidermal Melanogenesis
J. Biol. Chem.,
February 29, 2008;
283(9):
5486 - 5495.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bagheri, M. Nosrati, S. Li, S. Fong, S. Torabian, J. Rangel, D. H. Moore, S. Federman, R. R. LaPosa, F. L. Baehner, et al.
Genes and pathways downstream of telomerase in melanoma metastasis
PNAS,
July 25, 2006;
103(30):
11306 - 11311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. R. Erickson, L. M. Dunning, and J. L. Holtzman
The effect of aging on the chaperone concentrations in the hepatic, endoplasmic reticulum of male rats: the possible role of protein misfolding due to the loss of chaperones in the decline in physiological function seen with age.
J. Gerontol. A Biol. Sci. Med. Sci.,
May 1, 2006;
61(5):
435 - 443.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ostankovitch, V. Robila, and V. H. Engelhard
Regulated Folding of Tyrosinase in the Endoplasmic Reticulum Demonstrates That Misfolded Full-Length Proteins Are Efficient Substrates for Class I Processing and Presentation
J. Immunol.,
March 1, 2005;
174(5):
2544 - 2551.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Slominski, D. J. Tobin, S. Shibahara, and J. Wortsman
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
Physiol Rev,
October 1, 2004;
84(4):
1155 - 1228.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Hoek, D. L. Rimm, K. R. Williams, H. Zhao, S. Ariyan, A. Lin, H. M. Kluger, A. J. Berger, E. Cheng, E. S. Trombetta, et al.
Expression Profiling Reveals Novel Pathways in the Transformation of Melanocytes to Melanomas
Cancer Res.,
August 1, 2004;
64(15):
5270 - 5282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Francis, N. Wang, H. Parag, R. Halaban, and D. N. Hebert
Tyrosinase Maturation and Oligomerization in the Endoplasmic Reticulum Require a Melanocyte-specific Factor
J. Biol. Chem.,
July 3, 2003;
278(28):
25607 - 25617.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|